AdvisorShares Psychedelics ETF (Ticker: PSIL) began trading on the NYSE Acra exchange on Thursday, September 16th as the first U.S.-listed actively managed ETF to deliver dedicated investment exposure to psychedelics. All 5 are compared to help you decide which ETF to invest in or which ETF or Index to follow for the latest activity in the fledgling sector.
There are almost 100 relatively new sites available that cover various aspects of the fledgling but burgeoning cannabis and psychedelic markets but only 28 provide information of interest to current or potential investors.
This article identifies the 10 psychedelic substances undergoing extensive research, those with the most therapeutic and commercial potential and the companies that are most involved in such research to help you decide which offer the best investment opportunities.
Curious about the purported beneficial effects of psilocybin mushrooms on the mind, the writer decided to attend a guided hallucinogenic trip and found it to be the most important experience of his life.
The supposedly first and, supposedly, a “psychedelic” stocks ETF, was launched in the U.S. on May 27th. but it is not a true psychedelic stocks ETF nor is it the world’s first psychedelic ETF. This article uncovers what it really is.
This infographic is the first in a two-part series that explores how psychedelics have evolved over the last 6,000 years.
This infographic tells the story behind the prohibition of psychedelic substances, and how strict regulations resulted in a hugely stigmatized industry.
A Few Last Words:
- Click the “Like” button at the top of the page if you found this article a worthwhile read as this will help us build a bigger audience.
- Comment below if you want to share your opinion or perspective with other readers and possibly exchange views with them.
- Register to receive our free Market Intelligence Report newsletter (sample here) in the top right hand corner of this page.
- Join us on Facebook to be automatically advised of the latest articles posted and to comment on any of them.